ClinicalTrials.gg
CompletedNCT05829785Updated Oct 17, 2023

Influence of Obesity on Microvascular Reactivity During General Anesthesia

An observational study in Obesity, Anesthesia and Microcirculation, sponsored by Pusan National University Hospital. Completed at 1 site in South Korea. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-10-17.

Sponsored by Pusan National University Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
128
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study was to investigate the effect of obesity on changes in microvascular reactivity and tissue oxygen saturation (StO2) during general anesthesia using near-infrared spectroscopy in conjunction with vascular occlusion tests (VOT).

For this prospective observation investigation, a total of 128 patients who underwent elective surgery under general anesthesia at Pusan National University Hospital between June 2018 and February 2021 were participated in this study. Baseline StO2 on thenar eminence, hemodynamics, and laboratory profile were monitored before (Tpre) and 30 min after general anesthesia (Tpost). During vascular occlusion tests (VOT), the occlusion slope representing oxygen consumption of muscle and recovery slope representing microvascular reactivity were also collected at Tpre and Tpost. For analysis, the patients were divided into two groups: overweight (body mass index [BMI] ≥ 25 kg/m2) and normal weight (BMI \< 25).

Read the detailed description

Preoperative laboratory findings were obtained. Mean blood pressure (MBP), pulse oxygen saturation (SpO2), heart rate (HR), skin temperature, and VOT-derived measurements, including baseline tissue oxygen saturation (StO2), occlusion slope, minimum StO2, time to minimum StO2, recovery slope, maximum StO2, and time to baseline StO2 were recorded before (Tpre) and 30 min after general anesthesia (Tpost).

02

Conditions studied

  • Obesity
  • Anesthesia
  • Microcirculation

Browse trials for

Keywords

  • Obesity
  • Body mass index
  • Anesthesia, general
  • Microcirculation
03

In context

Obesity

6,583 studies on the registry are indexed under Obesity; 1,718 are open to participants now.

This study's enrollment of 128 is close to the median of 132 across 1,339 observational studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

Pusan National University Hospital is the lead sponsor of 80 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Subjects who underwent elective surgery under general anesthesia between 2018 and 2021 in Pusan national univ. hospital.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Subjects who underwent elective surgery under general anesthesia.

Exclusion criteria

Exclusion Criteria:

  • Society of Anesthesiologists (ASA) physical status > II
  • patients with a neuraxial block
  • uncontrolled hypertension
  • patients with major cardiovascular disease
  • diabetes
  • pregnant individuals
  • peripheral vascular disease
  • chronic venous insufficiency
  • smoking: Pack-years > 10
  • chronic obstructive and restrictive pulmonary disease
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
128 participants (actual)
Patient registry
No

Groups and cohorts

  • overweight group

    Subjects with a body mass index (BMI) ≥ 25

    Device: Near-infrared spectroscopy monitor

  • normal weight group

    Subjects with BMI \< 25

    Device: Near-infrared spectroscopy monitor

Interventions

  • DeviceNear-infrared spectroscopy monitor

    tissue oxygen saturation monitoring combined with vascular occlusion test

06

What researchers measure

Primary outcomes

  1. Recovery slope after general aneshtesia (Tpost)

    Representing microvascular reactivity (Tpost: 30 minutes after general anesthesia); recovery slope was calculated from deflation of the tourniquet until the recovery of StO2 to the baseline value.

    Time frame: 10 minutes

Secondary outcomes

  1. Recovery slope before general aneshtesia (Tpre)

    Representing microvascular reactivity (Tpre: before general anesthesia); recovery slope was calculated from deflation of the tourniquet until the recovery of StO2 to the baseline value.

    Time frame: 10 minutes

  2. Occlusion slope before general anesthesia (Tpre)

    representing oxygen consumption of muscle (Tpre: before general anesthesia); occlusion slope was defined as the slope of StO2 descent to the lowest value.

    Time frame: 10 minutes

  3. Occlusion slope before general anesthesia (Tpost)

    representing oxygen consumption of muscle (Tpost: 30 minutes after general anesthesia); occlusion slope was defined as the slope of StO2 descent to the lowest value.

    Time frame: 10 minutes

07

Study locations

1 site
  • Pusan National University Hospital
    Busan, 49241, South Korea
08

References and documents

Publications

  • Cho AR, Lee HJ, Kim HJ, Do W, Jeon S, Baek SH, Kim ES, Kwon JY, Kim HK. Microvascular Reactivity Measured by Dynamic Near-infrared Spectroscopy Following Induction of General Anesthesia in Healthy Patients: Observation of Age-related Change. Int J Med Sci. 2021 Jan 1;18(5):1096-1103. doi: 10.7150/ijms.52433. eCollection 2021. PubMed 33526968 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jun 2018 to primary completion in Feb 2021, 32 months.

Of 538 non-industry observational studies under Obesity, half reached primary completion within 43 months of starting (the median), counting those still running; a quarter within 20 and three quarters within 111. This study's 32 months is below that.

Counting every sponsor, half of 570 studies reached it within 40 months; a quarter within 19 and three quarters within 111.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 13, 2023
First posted
Apr 26, 2023
StartActual
Jun 1, 2018
Primary completionActual
Feb 28, 2021
CompletionActual
Feb 28, 2021
Last update
Oct 17, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 17, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05829785
Lead sponsor
Pusan National University Hospital
Responsible party
Hyeon-Jeong Lee (Dr., Pusan National University Hospital) — Principal investigator
First posted
Apr 26, 2023
Start date
Jun 1, 2018
Primary completion
Feb 28, 2021
Completion
Feb 28, 2021
Last update
Oct 17, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion